AxolotlBio is a Turkish-based startup specializing in regenerative medicine and tissue engineering products and solutions. The company's focus lies in high-resolution desktop 3D bioprinters and bioinks capable of producing functional three-dimensional living tissues. Founded in 2016, AxolotlBio has developed its products to be accessible to researchers, with a flexible open system architecture for construct design, thereby reducing the high costs associated with traditional 3D bioprinting systems. These qualities have made AxolotlBio's products the preferred platform for leading bioengineering laboratories worldwide. The company operates in the industries of Biotechnology, Health Care, Life Sciences, and Medical Devices. As of now, there are no public records of the last investment or the investors involved in AxolotlBio.
There is no investment information
No recent news or press coverage available for Axolotl Biosystems.